6. Vaccines in small cell carcinomas
In small cell carcinomas of the lung VACCINES
Vaccines can be a good choice when the tumor is reduced by your load. You can skew, Chu Fong Atzpodien or ask one of them an autologous vaccine or a vaccine with dendritic cells before you can get.
The RAS vaccine in patients with small cell lung cancer led to some stabilization. (Editorial Note: Addresses the doctor you ask us. Send him an email. )
You might also want to talk to Lloyd Old, an immunologist at Memorial Sloan Kettering, about the vaccine in small cell carcinomas. (Editorial Note: Addresses the doctor you ask us. Send him an email. ) I could even now call not reach. If you've got more information from him, I hear about love from you During the annual meeting of the American Society of Clinical Oncology was a few years ago, a small cell lung carcinoma vaccine presented by another person from Sloan Kettering, but we have never since heard from him.
This researcher was SC Grant, principal investigator of a vaccine protocol BEC2 plus BCG. (Editorial Note: Addresses the doctor you ask us. Send him an email. ) In a follow-up article refers to a very long survival (> 47 months). There is in the years after the presentation unfortunately silent about these developments occur. The last time I spoke to Grant, I realized that there was a shortage of raw material for his research. This must involve the BEC2, because there is no shortage of BCG.
But maybe you are lucky, because there is a trial run with BEC2 and BCG at the University Hospital of the Vrije Universiteit in Amsterdam. There is a phase III trial of adjuvant BCG and monoclonal antibody BEC2 for patients with small cell lung cancer in an average stage. If your current chemotherapy leads to complete or partial response, it is worthwhile to investigate this possibility further out. Maybe you are not eligible if the tumor load is too large. The contact Giuseppe Giaccone, President, (Editorial Note: Addresses the doctor you ask us. Send him an email. )
